Font : A-A+

Drug information on Orphipal (Orphenadrine) from GlaxoSmithKline Pharmaceuticals Ltd

Orphipal   Tablet   GlaxoSmithKline Pharmaceuticals Ltd Generic : Orphenadrine	12.41 50mg 10 Tablets

Update the Drug Info

Whiplash

Whiplash and Conditions that Mimic Whiplash

•   Most Common : Agitation, drowsiness, dizziness, emotion, hallucinations, headache and mental confusion.

•   Gastrointestinal : Constipation, gastric irritation, nausea and vomiting.

•   Heart : Palpitations and fast heart rate.

•   Genitourinary : Urination hesitancy and urinary retention.

•   Eye and ENT : Blurred vision, increased eye pressure, night blindness, pupil dilatation and nasal congestion.

PO- 150mg daily in divided doses increased by 50mg every 2-3 days. Maintenance dose of 150-300mg daily.
IV/IM- Adults - One 2 mL ampul (60 mg); may be repeated every 12 hours.

It comes as a tablet to take by mouth, with or without food.

Contraindicated in patients with increased eye pressure, intestinal obstruction and hypersensitivity.

• Caution should be exercised in patients with history of enlarged prostate, increased eye pressure, intestinal blockage, difficulty in swallowing, myasthenia gravis, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may cause drowsiness, dizziness, blurred vision, or lightheadedness, do not drive a car or operate machinery and get up slowly from bed while taking this medication.

• Avoid alcohol consumption.

Avoid excess dosage.

Store it at controlled room temperature (15°-30°C).